Navigation Links
Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients
Date:9/6/2008

utility of Oncotype DX by providing single gene reporting for the expression of estrogen and progesterone receptors. The company expects to further increase the clinical utility of its test by including single gene reporting for quantitative HER2 gene expression in all Oncotype DX reports by the end of 2008.

The first study (Abstract 13), conducted by Genomic Health and collaborators from the Eastern Cooperative Oncology Group and sanofi-aventis, demonstrated a high degree of overall concordance -- 95 percent -- between central IHC and quantitative RT-PCR using Oncotype DX for determining HER2 status. The study analyzed 755 patients with 0 to 3 positive lymph nodes who were enrolled in Intergroup study E2197, a large adjuvant breast cancer trial evaluating two different chemotherapy regimens.

The second study (Abstract 41) found a high degree of concordance -- 97 percent -- between RT-PCR using Oncotype DX and central laboratory FISH assessment of HER2 status. The study was conducted by Genomic Health and collaborators from Kaiser Permanente; the University of California, San Francisco; and PhenoPath, Inc. HER2 measurement was assessed by central FISH and quantitative RT-PCR using Oncotype DX in 568 patients from a large Kaiser Permanente case-control study (Habel et al., Breast Can Res 2006). As previously reported, this study also found a significantly greater risk of breast cancer death in patients who were determined to be HER2-positive by Oncotype DX. Since patients in both these studies did not have the option of Trastuzumab treatment, the direct relationship between HER2 and Trastuzumab treatment response could not be assessed.

"During tumor sample preparation for IHC or FISH analysis, variability in the preanalytic process may lead to differences in results and interpretation, and, consequently, to potentially inappropriate treatment decisions," said Frederick L. Baehner, M.D., Senior Pathologist at Genomic Health and lead author of both
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum
2. M. D. Anderson to Initiate Clinical Validation Study on Rosetta Genomics MicroRNA-based Diagnostic Assay Identifying the Origin of Cancer Metastases
3. First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology Receives Regulatory Approval
4. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
5. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
6. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
7. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
8. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
9. Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies
10. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
11. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... LONDON, Sept. 3, 2015 With a population ... largest country and therefore also its single largest potential ... years, China has led all major world economies in ... health expenditures, and government health expenditures. As an in ... developed markets of the United States, western European countries, ...
(Date:9/3/2015)... About cardiovascular implants ... or blockage of blood vessels. Cardiac disease is ... cholesterol, and high blood pressure. Coronary artery disease, ... failure are some of the major cardiac diseases. ... coronary arteries, is one of the most common ...
(Date:9/3/2015)... Sept. 3, 2015  WellCare Health Plans, Inc. (NYSE: ... , senior vice president and chief financial officer, is ... Healthcare Conference on Wednesday, September 9, 2015, at 9:25 ... webcast live. In addition, a replay of the webcast ... broadcast. Both the live broadcast and the replay will ...
Breaking Medicine Technology:IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13Global Cardiovascular Implants Market 2015-2019 2
... from a multicenter,trial monitoring CellCept(R) (mycophenolate mofetil) in ... presented today,at the American Transplant Congress (ATC). The ... with a therapeutic monitored dose of CellCept is ... CellCept, and the standard-dose of CNI,as it relates ...
... Results from Second Phase 3 Study of ... ... Pharmaceuticals,Inc., a specialty pharmaceutical company deriving significant new patient,benefits from proven ... clinical trials that will be included in the new,drug application (NDA) ...
Cached Medicine Technology:CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI 2CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI 3CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI 4CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI 5CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI 6Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008 2Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008 3
(Date:9/3/2015)... ... 2015 , ... The Beryl Institute announces 52 breakout sessions ... April 13-15 at Sheraton Hotel in Dallas, Texas. Patient Experience Conference is the ... healthcare leaders, staff, physicians, patients and families across the globe to convene, engage ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... Leadership® and Navigant Center for Healthcare Research and Policy Analysis has found physician ... , While 47 percent of respondents said their organizations conduct some ...
(Date:9/3/2015)... ... September 03, 2015 , ... For ... compression garments. However, graduated compression garments are an effective solution for reducing the ... Robyn Bjork, was recently sponsored by SIGVARIS for a unique opportunity ...
(Date:9/3/2015)... ... , ... Girl’s Night Out to benefit Core Compassion Project will be held ... in Monroe, North Carolina. The event food will be provided by Kate ... offers off-premise catering and event services from casual to elegant. They are also the ...
(Date:9/3/2015)... ... September 03, 2015 , ... Dr. Robert Winchell has been appointed director of ... Care at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 27. He will serve on the ... in care for the critically injured and the development, design and operations of trauma ...
Breaking Medicine News(10 mins):Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:Survey finds growing movement for physician leadership training 2Health News:Survey finds growing movement for physician leadership training 3Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 2Health News:SIGVARIS Supports the Lymphedema Treatment Act to Help Patients with Lymphedema 3Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 2Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 3Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 4Health News:Trauma Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College 5
... -- The National Cancer Institute recently awarded $7.2 million ... Consortium (SEP2C), led by Moffitt Cancer Center,s Daniel Sullivan, ... Clinical Investigations. The renewal is through September 2016. ... and some phase I trials across six member sites. ...
... studied in non-human primates by researchers at Wake Forest ... a potential tool for combating cardiovascular disease by increasing ... Supported by the National Institutes of Health and the ... in this week,s issue of the journal Nature ...
... A person who uses a manual wheelchair can burn up to ... on a flat surface, which is three times as much as ... same person can expend 127 calories while mopping and as much ... activities are done in a manual wheelchair. This is according ...
... austerity. A finely tuned system evolved early on to help cells ... they go. The system, a molecular switch found in organisms from ... in times of plenty and shuts it off when times are ... an investigator in the Department of Pathology at Beth Israel Deaconess ...
... -- Lowered testosterone levels are associated with the loss ... men, a new study finds. Loss of muscle mass ... problems, falls and bone fractures, the study,s authors say, and ... they age. That suggests that levels of sex hormones, ...
... over age 70 years of age can safely donate a kidney, ... Clinical Journal of the American Society Nephrology ( CJASN ... kidney but have limited options for donors; however, kidneys from these ... living donors. Because of a profound shortage in organs for ...
Cached Medicine News:Health News:New therapy shows promise for treating cardiovascular disease 2Health News:UT study looks at manual wheelchair use, exercise and calorie burning 2Health News:Unraveling the complex signaling that helps cells know when to grow, when to sit tight 2Health News:Unraveling the complex signaling that helps cells know when to grow, when to sit tight 3Health News:For Older Men, Lowered Testosterone May Mean Muscle Loss 2Health News:Never too old to donate a kidney? 2
...
Malis Curette, bayonet, titanium handle, stainless steel shaft, working distance 102 mm, length 203 mm....
Sundt Slim-Line Temporary Vessel Clips used for temporary vascular occlusion during intracranial surgical procedures. Non-magnetic, MP35N, MRI compatible, gold color. Bayonet....
Malis Needle Holders, bayonet, titanium. Working distance 2 1/2" (63 mm). Straight tip with width 0.6 mm....
Medicine Products: